The Power of Collective Expertise

At Velox, we believe in the power of collective expertise and a depth of applied knowledge. Our team, inspired by the depth, breadth, and diversity of expertise, comes together to inspire new possibilities and advance health. We are more than just a group of individuals; we are a team united by a shared passion for innovation that improves patient outcomes.

OUR CAPABILITIES

Market Research & Commercialization

  • Diabetes
    Women’s Health
    Wound Care
    Anesthesiology
    Respiratory
    Cardiovascular
    Dermatology
    Neurology
    Hematology
    Surgical


  • Upstream
    Product Development
    Concept Testing
    HCP Journey
    Usage & Attitudes

    Downstream
    Patient & Consumer Journey
    Pricing & Market Share Modeling
    Positioning & Messaging
    Branding
    Profiling & Segmentation

    Market Access and Reimbursement
    Landscape assessment
    Strategy and execution
    Coverage, coding, and reimbursement
    Continued support including payer campaigns, value dossiers, and HEOR

Studies Recruitment

  • Usability Studies Recruitment
    Human Factors Recruitment

    Focus Groups
    Online Testing



OUR LEADERSHIP TEAM


SUMAN DATTA, MBA/MS | FOUNDER & CEO

Suman, with 20 years in leadership, and consulting at Capgemini, founded Velox to commercialize medical products. His expertise spans devices, diagnostics, biologics, and digital health, driving successful launches, including a $18M+ business in Diabetes therapy and developing the blueprint for a $100 million-per-year digital healthcare services company. A strategic thinker and global leader, Suman leverages his background to advance Velox, benefiting clients worldwide.

STUART SUNDEM | HEAD OF CLIENT ENGAGMENT

Stuart, with 25+ years in medical devices and healthcare, specializes in product design and device integration. commercial operations from concept to commercialization, marketing, and customer relations, having worked at Medtronic, Smiths Medical, Tandem Diabetes Care, and Beta Bionics. He holds a Masters in Public and Community Health from Minnesota State University and attended the University of Minnesota Carlson School of Healthcare Management ISP Executive program

JOHN DIERKER | OPERATIONS DIRECTOR

John Dierker, Director of Operations & Integration at Velox Operations, served nine years as a U.S. Coast Guard Intelligence Officer. He holds a BS from the Coast Guard Academy and an MS from National Intelligence University. His expertise includes project and risk management, and strategic planning. A proven organizational leader, John lives in Fort Worth, Texas with his family.

Jason is a seasoned financial expert with over 25 years of experience in the industry. As a Fellow Certified Chartered Accountant (FCCA), he is well-versed in US, UK, and international accounting standards. Jason began his journey in public accounting, spending seven years in London where he specialized in external audits. At Velox, Jason is responsible for Accounting Controllership and Financial Planning & Analysis (FP&A), shaping the financial success of the organization.

JASON DAVIES | FINANCE CONTROLLER

OUR RESEARCH TEAM

Rodrigo Sampera, MBA
Associate Director, Research
Rodrigo brings over two decades of market research expertise, specializing in a broad spectrum of therapeutic areas including oncology, cardiovascular diseases, respiratory issues, and infectious diseases.

Surita Gangarh
Associate Director, Research
Surita excels in qualitative market research across various therapy areas such as respiratory disease, mental health, and women's health conditions, in addition to device expertise.

Gillian Benson
Senior Research Manager
A market research pro with a passion for UX/UI research, and a deep understanding of diabetes, respiratory, and hygienic product research, Gillian uncovers insights that inform effective strategies.

Sofia Pasechnikova
Research Manager
Sofia brings specialized experience in therapeutic areas such as oncology, cardiovascular, and respiratory, encompassing an array of medical devices, diagnostics, and digital health solutions, HCP journey mapping, and concept testing.

OUR RECRUITING TEAM


Dawei Zhang
Senior Recruitment Project Manager
A recruitment pro with 17 years of experience in the market research industry, including diabetes, dermatological issues, and cancers with HCPs.

Sabrina Tartaglino
Senior Recruitment Project Manager
Sabrina is a specialist in recruitment for human factor and usability. With an agile approach to project management, Sabrina is always ready to promptly react to any changes.

Rivka Sutera
Recruitment Project Manager
Rivka combines expertise in managing complex projects and leading cross-functional teams with a rich background in project coordination, technical writing, and quality management.

Danai Markousi
Recruitment Project Manager
With an education in Biomedical Sciences at UCL, Danai’s professional experience includes managing and optimizing patient recruitment in numerous pharmaceutical studies, including drug development.

Tamar Kirby
Recruitment Project Manager
Tamar is an experienced market research professional specializing in recruiting participants for studies researching medical devices, software, and diseases such as sickle cell disease and diabetes.

UK BUSINESS TEAM


Luci Talbot Clarke
UK Director of Operations & HR
Luci’s operational experience spans over 20 years; honing her skills managing the production of Formula 1 TV series, she worked through the ranks to become Managing Director of one of London’s most prestigious TV post-production companies.

Iain Hutchinson
UK Finance Director
Iain’s experience spans over 30 years within many sectors including auditing, insurance, marketing, design, publishing, and retail giving him exposure to many different types of people and ways of working.

BOARD OF DIRECTORS

  • Ross Grossman is a seasoned HR executive with experience at top companies like Regeneron Pharmaceuticals, Novartis Pharmaceuticals, Prudential Financial, and UBS. He played a significant role in Regeneron's growth, where during his tenure the company launched four new drugs, expanded its workforce from a few hundred to over 5,000 employees, and increased its market capitalization from under $1 billion to over $60 billion.

    Dr. Grossman holds a B.A. in English from California State University, Fullerton, an M.A. and Ph.D. in English from Claremont Graduate University, and an MBA from UCLA. He serves on the Board of Trustees at the Keck Graduate Institute and the Center for Excellence in Education and is a member of the Executive Committees of both boards. Additionally, Dr. Grossman advises small companies, biotech startup CEOs, CHROs, and management teams on strategies for rapid growth. Clients have included IBM, Regeneron Pharmaceuticals, Alnylam Pharmaceuticals, PTC Therapeutics, Myovant Sciences, Valo Health, Vaxart, and Legend Biotechnology.

  • Saumil is a search fund investor based in Seattle with experience in working with dozens of searchers on a variety of deals across industries since 2016. He previously served as a board member for the Gastro Center of Maryland and as a board observer for the Kotter Group and Ascend Software, all acquired through search funds.

    Saumil started his career in Boston as a management consultant at Bain & Company and later worked as a private equity investor at Charlesbank Capital Partners. He joined Trilogy Search Partners in 2019 as Vice President and worked to deploy a $75M fund into search fund deals. Saumil graduated summa cum laude from the Huntsman Program at the University of Pennsylvania with degrees from the Wharton School and the College of Arts and Sciences. He volunteers as a pro bono consultant for minority, veteran and women-owned small businesses and is an avid fan of college basketball and the NBA.

  • Shakeeb Alam is an investor, entrepreneur, and board member with over 25 years of investing and business experience. Throughout his career, Shakeeb has backed dozens of CEOs and management teams building companies across different sectors of the economy. Shakeeb has significant experience with high-growth healthcare services businesses that are scaling both organically and via acquisitions.

    Shakeeb is the Co-Founder and President of East Bridge Capital Management, a Boston-based institutional investment firm that is focused on long-term compounding opportunities. Prior to forming East Bridge, he invested across both public and private markets at Highfields Capital and GTCR. Shakeeb began his professional career as an investment banker in the M&A Group at Bear Stearns.

    In addition to his business activities, Shakeeb is actively engaged in his communities. He serves on the board of directors of the University of Illinois Foundation (UIF), the university system’s private foundation. He currently serves as Vice Chairman of UIF’s Investment Committee, which oversees the UIF Investment Office and $2.5 billion endowment.

    Shakeeb earned a BS from the University of Illinois at Urbana-Champaign and an MBA from the Harvard Business School.

  • Benoit Berthoux is a tech and life sciences growth leader and investor with a passion for building diverse, high-performing teams and profitable P&Ls. With 20 years in professional services and consulting, he was recently Managing Director at Accenture in charge of the Life Sciences West business (Strategy, Consulting, Technology, AI, Interactive, Outsourcing) where he 10X-ed the business in less than five years. Prior to Accenture, Benoit was a VP at Capgemini Consulting in charge of the Life Sciences NA practice.

    In health and life sciences, he has broad experience in leading global strategy and operations projects with Fortune 500 companies with a goal to boost sales, accelerate revenue generation and improve the bottom-line. His expertise covers corporate strategy and transformation (organic and inorganic), innovation, product strategy and lifecycle management, digital transformation, operations (commercial, finance, IT), patient services, managed-care and distribution. His past clients include Roche-Genentech, Gilead, Amgen, McKesson, Novartis, Fortive, Abbott, and J&J.

    Benoit now focuses on investing in and developing leading-edge blockchain, AI and future-of-work projects.

Who we’ve worked with

Abbott Diabetes Care white logo
Novartis white logo
Roche white logo
Getinge white logo
Medtronic white logo